ANEUVO

Private

Developer of non-invasive neuromodulation technology for spinal cord injury rehabilitation. The ExaStim Stimulation System is a portable bioelectronic device that sends electrical pulses through a 16-channel multi-electrode array to stimulate nerves along the spinal cord. FDA Breakthrough Device Designation. CE Mark certified in 2025.

Founders Yi-Kai Lo
CEO Yi-Kai Lo

Company

Founded
2016
Headquarters
Los Angeles, United States

Financials

Total Funding
$40M
Sectors
Healthtech Hardware
aneuvo.com

Funding History

4 rounds
Series C Mar 5, 2026
$22M
Catcher Technology (Lead)
Series B Jun 1, 2023
$10M
Magnify (Lead)
Series A Jan 1, 2021
$5M
Seed Jan 1, 2019
$3M
US National Science Foundation

Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.